A formal asymmetric synthesis of Calabar bean alkaloids

Chemical and Pharmaceutical Bulletin

Volumn 44, Issue 4, 1996, Pages 715-719

  Node, Manabu ^a   Hao, Xiao Jiang ^b   Nishide, Kiyoharu ^a   Fuji, Kaoru ^c  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b KUNMING INSTITUTE OF BOTANY   (China)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

( ) eserethole; ( )physostigmine; aromatization; asymmetric nitroolefination; Diels Alder reaction; nitro group

Indexed keywords

2 METHYL 2 (2 NITROETHENYL) DELTA VALEROLACTONE; ALKALOID; CHOLINESTERASE INHIBITOR; ESERETHOLE; ESERIDINE; LACTONE; NITRO DERIVATIVE; PHYSOSTIGMINE; PHYSOSTIGMINE DERIVATIVE; PHYSOVENINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AROMATIZATION; ARTICLE; BEAN; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL REACTION; CHIRALITY; DRUG STRUCTURE; DRUG SYNTHESIS; GLAUCOMA; MEDICINAL PLANT; MYASTHENIA GRAVIS; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0029919045     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.44.715     Document Type: Article

References (70)

1. Preliminary communication see: Node M., Hao X., Fuji K., Chem. Lett., 1991, 57-60.
2. a) Brossi A., Schönenberger B., Clark O. E., Ray R., FEBS Lett., 201, 190-192 (1986);
3. b) Yu Q.-S., Atack J. R., Rapoport S. I., Brossi A., ibid., 234, 127-130 (1988);
4. c) Yu Q.-S., Atack J. R., Rapoport S. I., Brossi A., J. Med. Chem., 31, 2297-2300 (1988);
5. d) Atack J. R., Yu Q.-S., Soncrant T. T., Brossi A., Rapoport S. I., J. Pharmacol. Exp. Ther., 249, 194-202 (1989).
6. Axelsson U., Acta Ophthalmol., Suppl., 102, 1-37 (1969).
7. Walker M. B., Lancet, 226, 1200-1201 (1934).
8. a) Davis K. L., Mohs R. C., Am. J. Psychiatry, 139, 1421-1424 (1982);
9. b) Beller S. A., Overall J. E., Swann A. C., Psychopharmacology, 87, 147-151 (1985);
10. c) Hartvig P., Wiklund L., Lindström B., Acta Anaesthesiol Scand., 30, 177-182 (1986).
11. A review of Calabar bean alkaloids: a) Takano S., Ogasawara K., "The Alkaloids," Vol. 36, ed. by Brossi A., Academic Press, New York, 1989, pp. 225-251;
12. b) Saxton J. E., Natural Product Reports, 1989, 1;
13. c) Brossi A., J. Med. Chem., 33, 2311-2319 (1990);
14. d) Overman L. E., Pure Appl. Chem., 66, 1423-1430 (1994).
15. dl-Physostigmine: a) Julian P. L., Pikl J., J. Am. Chem. Soc., 57, 755-757 (1935);
16. b) Wijnberg J. B. P. A., Speckamp W. N., Tetrahedron, 34, 2399-2404 (1978);
17. c) Shishido K., Shitara E., Komatsu H., Hiroya K., Fukumoto K., Kametani T., J. Org. Chem., 51, 3007-3011 (1986);
18. d) Horne S., Taylor N., Collins S., Rodrigo R., J. Chem. Soc., Perkin Trans. 1, 1991, 3047-3051;
19. e) Grieco P. A., Carroll W. A., Tetrahedron Lett., 33, 4401-4404 (1992);
20. f) Yu Q.-S., Lu B.-Y., Heterocycles, 39, 519-525 (1994);
21. g) Morales-Rios M. S., Bucio M. A., Joseph-Nathan P., Tetrahedron Lett., 35, 881-882 (1994);
22. h) Morales-Rios M. S., Bucio M. A., García-Martinez C., Joseph-Nathan P., ibid., 35, 6087-6088 (1994).
23. Absolute configuration of (-)-physostigmine: i) Longmore R. B., Robinson B., Chem. Ind. (London), 1969, 622-623;
24. j) Hill R. K., Newkome G. R., Tetrahedron, 25, 1249-1260 (1969).
25. (-)-Physostigmine: k) Takano S., Goto E., Hirama M., Ogasawara K., Chem. Pharm. Bull., 30, 2641-2643 (1982);
26. l) Takano S., Moriya M., Iwabuchi Y., Ogasawara K., Chem. Lett., 1990, 109-112;
27. m) Node M., Itoh A., Masaki Y., Fuji K., Heterocycles, 32, 1705-1707 (1991);
28. n) Takano S., Moriya M., Ogasawara K., J. Org. Chem., 56, 5982-5984 (1991);
29. o) Lee T. B. K., Wong G. S. K., ibid., 56, 872-875 (1991);
30. p) Marino J. P., Bogdan S., Kimura K., J. Am. Chem. Soc., 114, 5566-5572 (1992);
31. q) Ashimori A., Matsuura T., Overman L. E., Poon D. J., J. Org. Chem., 58, 6949-6951 (1993).
32. Optical resolution: see 7a. r) Schönenberger B., Brossi A., Helv. Chim. Acta, 69, 1486-1497 (1986);
33. s) Yu Q.-S., Brossi A., Heterocycles, 27, 1709-1712 (1988);
34. (+)-Physostigmine: see 7l. t) Yu Q.-S., Brossi A., Heterocycles, 27, 745-750 (1988);
35. u) Takano S., Sato T., Inomata K., Ogasawara K., ibid., 31, 411-414 (1990).
36. (-)-Physostigmine analogues: a) Crich D., Davies J. W., J. Chem. Soc., Chem. Commun., 1989, 1418-1419;
37. b) Marino J. P., Kim M.-W., Lawrence R., J. Org. Chem., 54, 1782-1784 (1989);
38. c) Takase S., Uchida I., Tanaka H., Aoki H., Tetrahedron, 42, 5879-5886 (1986);
39. d) Ikeda M., Matsugashita S., Tamura Y., J. Chem. Soc., Perkin Trans. 1, 1977, 1770-1772.
40. a) Fuji K., Node M., Nagasawa H., Naniwa Y., Terada S., J. Am. Chem. Soc., 108, 3855-3856 (1986);
41. b) Fuji K., Node M., Nagasawa H., Naniwa Y., Taga T., Machida K., Snatzke G., ibid., 111, 7921-7925 (1989);
42. c) Node M., Kurosaki R., Hosomi K., Inoue T., Nishide K., Ohmori T., Fuji K., Tetrahedron Lett., 36, 99-102 (1995);
43. d) Nishide K., Kurosaki R., Hosomi K., Imazato H., Inoue T., Node M., Ohmori T., Fuji K., Tetrahedron, 51, 10857-10866 (1995).
44. a) Danishefsky S., Kitahara T., J. Am. Chem. Soc., 96, 7807-7908 (1974);
45. b) Danishefsky S., Prisbylla M. P., Hiner S., J. Am. Chem. Soc., 100, 2918-2920 (1978).
46. The exo selective Diels Alder reaction of nitroolefins with Danishefsky's diene was generalized and will be reported elsewhere. See the following references on the endo selective Diels-Alder reaction of nitroolefins with Danishefsky's diene: a) Ono N., Miyake H., Kamimura A., Kaji A., J. Chem. Soc., Perkin Trans. 1, 1987, 1929-1935;
47. b) Kraus G. A., Thurston J., Thomas P. J., Jacobson R. A., Su Y., Tetrahedron Lett., 29, 1879-1882 (1988).
48. We found a new type of aromatization of the six-membered ring of 5 under acidic conditions (p-TsOH, MeOH) to the anisole derivative, and applied it to the asymmetric syntheses of (-)-aphanorphine and (-)-eptazocine, see: Node M., Imazato H., Kurosaki R., Kawano Y., Inoue T., Nishide K., Fuji K., Heterocycles, 42, 811-819 (1996).
49. The reduction of the nitro group in 5 under usual conditions with palladium carbon in a hydrogen atmosphere did not occur.
50. Lombardo L., Organic Synthesis, 65, 81-89 (1987).
51. Tamura Y., Yoshimoto Y., Chem. Ind., 1980, 888-889.
52. Node M., Ohta K., Kajimoto T., Nishide K., Fujita E., Fuji K., Chem. Pharm. Bull., 31, 4178-4180 (1983).
53. Haefliger W., Klöppner E., Helv. Chim. Acta, 65, 1837-1852 (1982).
54. (-)-Eserethole, see 7a, 19a. dl-Eserethole, see 7b, and Smith R., Livinghouse T., J. Org. Chem., 48, 1554-1555 (1983).
55. a) Polonovski M., Bull. Soc. Chim. Fr. Sér. 4, 17, 235-244 (1915);
56. b) Polonovski M., Nitzberg C., ibid., 19, 33-37 (1916);
57. c) Polonovski M., ibid., 21, 191-200 (1917).
58. Physovenine: structure; a) Robinson B., J. Chem. Soc., 1964, 1503-1506.
59. dl-Physovenine, see 7c, 7d, and 7f; b) Longmore R. B., Robinson B., Chem. Ind., 1965, 1297-1298;
60. c) Shishido K., Azuma T., Shibuya M., Tetrahedron Lett., 31, 219-220 (1990);
61. d) Clark A. J., Jones K., Tetrahedron, 48, 6875-6882 (1992);
62. e) Yu Q.-S., Liu C., Brzostowska M., Chrisey L., Brossi A., Greig N. H., Alack J. R., Soncrant T. T., Rapoport S. I., Radunz H.-E., Helv. Chim. Acta, 74, 761-766 (1991);
63. f) Longmore R. B., Robinson B., Chem. Ind. (London), 1966, 1638-1639. (-)-Physovenine: see 7n.
64. Geneserine structure: a) Hootele C., Tetrahedron Lett., 1969, 2713-2716;
65. b) Robinson B., Moorcroft D., J. Chem. Soc., (C), 1970, 2077-2078;
66. c) Yu Q.-S., Yeh H. J. C., Brossi A., J. Nat. Prod., 52, 332-336 (1989).
67. Total synthesis of dl-geneserine: d) Shishido K., Hiroya K., Komatsu H., Fukumoto K., Kametani T., J. Chem. Soc., Chem. Commun., 1986, 904-905;
68. e) Idem, J. Chem. Soc., Perkin Trans. 1, 1987, 2491-2495;
69. f) Wright C., Shulkind M., Jones K., Thompson M., Tetrahedron Lett., 28, 6389-6390 (1987).
70. Degradation of (-)-physostigmine to (-)-eseroline: Yu Q.-S., Schönenberger B., Brossi A., Heterocycles, 26, 1271-1275 (1987).